Physician Assistant in Hanscom Afb, MA Accepting Medicare
4 Physician Assistant nurses found. Showing 1 - 4
 Mrs. Edith Luz Skelly, PA Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 90 Vandenberg Dr, Hanscom Afb, MA 01731 Phone: 781-225-6789 |
Rebecca Charette, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 90 Vandenberg Dr Bldg 1900, Hanscom Afb, MA 01731 Phone: 617-834-9540 Fax: 781-225-2576 |
 David Anthony Digregorio, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 90 Vandenberg Dr, Hanscom Afb, MA 01731 Phone: 508-294-2741 |
Mr. Mohammed Fuad, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 66 Mds (afmc), 90 Vandenberg Dr. Bldg. 1900, Hanscom Afb, MA 01731 Phone: 781-225-6789 |
News Archive
Anthrax defenses need to be strengthened: Experts
It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation now has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.
New test may help detect Parkinson's disease in early stages of illness
A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer.
Vanillin could prevent or reduce psoriatic skin inflammation
Small amounts of artificial vanilla extract, also known as vanillin, are in a wide range of products, from baked goods to perfumes.
Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.
BronchoGen genomic test meets primary endpoint in AEGIS-2 clinical trial
Allegro Diagnostics Corp. today announced that the AEGIS-2 clinical trial has met its primary endpoint, demonstrating that the BronchoGen genomic test improves the accuracy of lung cancer diagnosis when used in combination with bronchoscopy.
› Verified 9 days ago